BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36216080)

  • 1. A germline STAT6 gain-of-function variant is associated with early-onset allergies.
    Suratannon N; Ittiwut C; Dik WA; Ittiwut R; Meesilpavikkai K; Israsena N; Ingrungruanglert P; Dalm VASH; van Daele PLA; Sanpavat A; Chaijitraruch N; Schrijver B; Buranapraditkun S; Porntaveetus T; Swagemakers SMA; IJspeert H; Palaga T; Suphapeetiporn K; van der Spek PJ; Hirankarn N; Chatchatee P; Martin van Hagen P; Shotelersuk V
    J Allergy Clin Immunol; 2023 Feb; 151(2):565-571.e9. PubMed ID: 36216080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT6 gain-of-function variant exacerbates multiple allergic symptoms.
    Takeuchi I; Yanagi K; Takada S; Uchiyama T; Igarashi A; Motomura K; Hayashi Y; Nagano N; Matsuoka R; Sugiyama H; Yoshioka T; Saito H; Kawai T; Miyaji Y; Inuzuka Y; Matsubara Y; Ohya Y; Shimizu T; Matsumoto K; Arai K; Nomura I; Kaname T; Morita H
    J Allergy Clin Immunol; 2023 May; 151(5):1402-1409.e6. PubMed ID: 36538978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease.
    Sharma M; Leung D; Momenilandi M; Jones LCW; Pacillo L; James AE; Murrell JR; Delafontaine S; Maimaris J; Vaseghi-Shanjani M; Del Bel KL; Lu HY; Chua GT; Di Cesare S; Fornes O; Liu Z; Di Matteo G; Fu MP; Amodio D; Tam IYS; Chan GSW; Sharma AA; Dalmann J; van der Lee R; Blanchard-Rohner G; Lin S; Philippot Q; Richmond PA; Lee JJ; Matthews A; Seear M; Turvey AK; Philips RL; Brown-Whitehorn TF; Gray CJ; Izumi K; Treat JR; Wood KH; Lack J; Khleborodova A; Niemela JE; Yang X; Liang R; Kui L; Wong CSM; Poon GWK; Hoischen A; van der Made CI; Yang J; Chan KW; Rosa Duque JSD; Lee PPW; Ho MHK; Chung BHY; Le HTM; Yang W; Rohani P; Fouladvand A; Rokni-Zadeh H; Changi-Ashtiani M; Miryounesi M; Puel A; Shahrooei M; Finocchi A; Rossi P; Rivalta B; Cifaldi C; Novelli A; Passarelli C; Arasi S; Bullens D; Sauer K; Claeys T; Biggs CM; Morris EC; Rosenzweig SD; O'Shea JJ; Wasserman WW; Bedford HM; van Karnebeek CDM; Palma P; Burns SO; Meyts I; Casanova JL; Lyons JJ; Parvaneh N; Nguyen ATV; Cancrini C; Heimall J; Ahmed H; McKinnon ML; Lau YL; Béziat V; Turvey SE
    J Exp Med; 2023 May; 220(5):. PubMed ID: 36884218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma.
    Minskaia E; Maimaris J; Jenkins P; Albuquerque AS; Hong Y; Eleftheriou D; Gilmour KC; Grace R; Moreira F; Grimbacher B; ; Morris EC; Burns SO
    J Clin Immunol; 2023 Oct; 43(7):1611-1622. PubMed ID: 37316763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6.
    Baris S; Benamar M; Chen Q; Catak MC; Martínez-Blanco M; Wang M; Fong J; Massaad MJ; Sefer AP; Kara A; Babayeva R; Eltan SB; Yucelten AD; Bozkurtlar E; Cinel L; Karakoc-Aydiner E; Zheng Y; Wu H; Ozen A; Schmitz-Abe K; Chatila TA
    J Allergy Clin Immunol; 2023 Jul; 152(1):182-194.e7. PubMed ID: 36758835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond.
    ;
    Trends Immunol; 2024 Feb; 45(2):138-153. PubMed ID: 38238227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage and association studies of STAT6 gene polymorphisms and allergic diseases.
    Tamura K; Suzuki M; Arakawa H; Tokuyama K; Morikawa A
    Int Arch Allergy Immunol; 2003 May; 131(1):33-8. PubMed ID: 12759487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning while treating: Gain-of-function STAT6 variants in severe allergic disease.
    Smith TD; Doherty TA
    Cell Rep Med; 2023 May; 4(5):101040. PubMed ID: 37196636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation by STAT6.
    Goenka S; Kaplan MH
    Immunol Res; 2011 May; 50(1):87-96. PubMed ID: 21442426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activation of signal transducer and activator of transcription 6 in B cells from allergic children and their non-allergic siblings.
    Deveikaite V; Fila C; Laurencikiene J; Klein E; Kihlström A; Lilja G; Ekström ES; Severinson E
    Clin Exp Allergy; 2004 Apr; 34(4):576-82. PubMed ID: 15080810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline STAT6 gain-of-function variants cause severe allergy.
    Yamashita M; Morio T
    J Allergy Clin Immunol; 2023 May; 151(5):1252-1254. PubMed ID: 36958638
    [No Abstract]   [Full Text] [Related]  

  • 12. DNA vaccine encoding Der p2 allergen down-regulates STAT6 expression in mouse model of allergen-induced allergic airway inflammation.
    Qiu J; Li GP; Liu ZG; Ran PX; Zhong NS
    Chin Med J (Engl); 2006 Feb; 119(3):185-90. PubMed ID: 16537002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.
    Liddiard K; Welch JS; Lozach J; Heinz S; Glass CK; Greaves DR
    BMC Mol Biol; 2006 Nov; 7():45. PubMed ID: 17134490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology.
    Karpathiou G; Papoudou-Bai A; Ferrand E; Dumollard JM; Peoc'h M
    Pathol Res Pract; 2021 Jul; 223():153477. PubMed ID: 33991851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression.
    Schedel M; Frei R; Bieli C; Cameron L; Adamski J; Lauener R; Kabesch M
    J Allergy Clin Immunol; 2009 Sep; 124(3):583-9, 589.e1-6. PubMed ID: 19665768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcription factor STAT3 is required for T helper 2 cell development.
    Stritesky GL; Muthukrishnan R; Sehra S; Goswami R; Pham D; Travers J; Nguyen ET; Levy DE; Kaplan MH
    Immunity; 2011 Jan; 34(1):39-49. PubMed ID: 21215659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4Rα Inhibition for Severe "Eosinophilic Gastroenteritis, Allergy, and Anaphylaxis" Syndrome due to a Gain-of-Function Variant in STAT6.
    Faguer S; Delabesse E; Paul C; Pasquet M
    J Clin Immunol; 2023 Dec; 44(1):29. PubMed ID: 38133747
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of STAT6 genetic variants with childhood atopic dermatitis in Taiwanese population.
    Lee YL; Yen JJ; Hsu LC; Kuo NW; Su MW; Yang MF; Hsiao YP; Wang IJ; Liu FT
    J Dermatol Sci; 2015 Sep; 79(3):222-8. PubMed ID: 26048407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells.
    Heller NM; Matsukura S; Georas SN; Boothby MR; Rothman PB; Stellato C; Schleimer RP
    Am J Respir Cell Mol Biol; 2004 Nov; 31(5):573-82. PubMed ID: 15297269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly-ADP ribose polymerase-14 limits severity of allergic skin disease.
    Krishnamurthy P; Da-Silva-Arnold S; Turner MJ; Travers JB; Kaplan MH
    Immunology; 2017 Nov; 152(3):451-461. PubMed ID: 28653395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.